Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP versus gonadotropin-based treatment for ovarian rejuvenation in diminished ovarian reserve
IRCT20151013024512N7Phase 2Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Feb 2021
- Modality
- Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of autologous platelet-rich plasma in Diminished Ovarian Reserve (DOR) and female infertility (3 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Increasing AMH level, Increasing AFC and 1 more. Started Feb 2021; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
Diminished Ovarian Reserve (DOR)female infertility
Beyond the preview
Go deeper on IRCT20151013024512N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151013024512N7.